XENON PHARMACEUTICALS INC. Preferred Stock, Shares Subscribed but Unissued
XENON PHARMACEUTICALS INC. (XENE) had Preferred Stock, Shares Subscribed but Unissued of 0 shares as of 2014-11-10, per its 10-Q/A filed 2015-08-13.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockShareSubscriptions · last filed 2015-08-13
- 2014-11-10: Preferred Stock, Shares Subscribed but Unissued 0.00 shares.
| Period end | Preferred Stock, Shares Subscribed but Unissued |
|---|---|
| 2014-11-10 | 0.00 shares 10-Q/A · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |